Infinity Pharmaceuticals, Inc. Other Accrued Liabilities, Current
Infinity Pharmaceuticals, Inc. had Other Accrued Liabilities, Current of $401.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Notes › Payables and Accruals
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2023-08-10
- 2023-06-30: Other Accrued Liabilities, Current $401.00K.
- 2023-03-31: Other Accrued Liabilities, Current $492.00K.
- 2022-12-31: Other Accrued Liabilities, Current $655.00K.
- 2022-09-30: Other Accrued Liabilities, Current $1.24M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $401.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $492.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $655.00K 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $1.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.51M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.42M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $413.00K 10-K · filed 2023-03-28 | $976.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $1.29M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $1.11M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $972.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $832.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $881.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $628.00K 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $640.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $848.00K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.44M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $1.87M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $1.44M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.24M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $1.07M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $920.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.40M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.51M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.74M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.14M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $1.28M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $2.85M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.03M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.07M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $3.05M 10-K · filed 2017-03-14 | $3.19M 10-K · filed 2016-02-23 |
| 2015-09-30 | $4.28M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.54M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.73M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $1.96M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $3.05M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.53M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.15M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $2.02M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $1.93M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.17M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $2.25M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.58M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $2.31M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $3.25M 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $3.44M 10-K · filed 2013-03-05 |